동물세포배양을 통한 백신 생산의 현황과 미래전망
Current Status and Perspectives of Cell Culture-Based Vaccine Production
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Vaccines, especially for viruses, have been produced from egg-based manufacturing process. The method is simple and easy to set up the manufacturing process. However, the method has many problems in quality control, limit of manufacturing capacity, and ethical issues. Over the last decade, an alternative method, which manufactures vaccines using cell culture-based system, has received great attention to overcome the problems in egg-based vaccine production. This article examines current status and perspectives of cell culture-based vaccine production.
Abstract
Vaccines, especially for viruses, have been produced from egg-based manufacturing process. The method is simple and easy to set up the manufacturing process. However, the method has many problems in quality control, limit of manufacturing capacity, and ethical issues. Over the last decade, an alternative method, which manufactures vaccines using cell culture-based system, has received great attention to overcome the problems in egg-based vaccine production. This article examines current status and perspectives of cell culture-based vaccine production.
참고문헌 (22)
- "Complete list of vaccines licensed for immunization and distribution in the US"[URL]
- "백신 안전사용을 위한 핸드북", 식약청, ~ (2009)
- 이정길, "cGMP 총론", 고려대학교한국바이오산업협회, ~ (2006)
- Jeffrey, B. U, "Vaccine manufacturing: challenges and solutions", Nature Biotechnol., 24, pp.1377~1383 (2006)
- Copier, J, "Cell based cancer vaccines: Regulatory and commercial development", Vaccine, 25S, pp.B35~46 (2007)
- 심층정보분석보고서 - 백신, , 한국과학기술정보연구원 (KISTI), ~ (2002)
- Pham, P. L, "Large-scale transfection of mammalian cells for the fast production of recombinant protein", Mol. Biotechnol., 34, pp.225~237 (2006)
- Cox, M. M, "FluBlok, a recombinant hemagglutinin influenza vaccine", Influenza Other Respi. Viruses, 2, pp.211~219 (2008)
- Grillberger, L, "Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells", Biotechnol. J., 4, pp.186~201 (2009)
- Hacker, D, "25 years of recombinant proteins from reactor-grown cells – where do we go from here?", Biotechnol. Adv., 27, pp.1023~1027 (2009)
- Hossler, P, "Optimal and consistent protein glycosylation in mammalian cell culture", Glycobiology, 19, pp.936~949 (2009)
- Wu,S.C, "RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells", Biotechnol. Adv., 27, pp.417~422 (2009)
- Jang, J, "Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts", Appl. Microbiol. Biotechnol., 85, pp.1509~1520 (2010)
- "정부 정책 변화와 국내 백신의약품 시장 전망", 하나금융경영연구소, ~ (2005)